The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Melanoma Cancer Diagnostics Market Research Report 2025
Synopsis
Melanoma is a type of skin cancer developing from pigment-containing cells known as melanocytes. Melanoma cancer diagnostics is to diagnose melanoma with biopsy. During a biopsy, all or the part of mole or growth over the skin is removed to test and analyze the sample. Common biopsy procedures used to diagnose melanoma are punch biopsy, incisional biopsy, and excisional biopsy.
The global Melanoma Cancer Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Melanoma Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melanoma Cancer Diagnostics.
Report Scope
The Melanoma Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Melanoma Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Melanoma Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB Sciences
Incyte
Merck
Novartis
Pierre Fabre
Amgen
AstraZeneca
Bristol-Myers Squibb
Daiichi Sankyo
Segment by Type
Fluorescent In Situ Hybridization (FISH) Tests
Comparative Genomic Hybridization (CGH) Tests
Immunohistochemical (IHC) Tests
Segment by Application
Hospitals
Clinics
Cancer Research Centres
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Melanoma Cancer Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Melanoma is a type of skin cancer developing from pigment-containing cells known as melanocytes. Melanoma cancer diagnostics is to diagnose melanoma with biopsy. During a biopsy, all or the part of mole or growth over the skin is removed to test and analyze the sample. Common biopsy procedures used to diagnose melanoma are punch biopsy, incisional biopsy, and excisional biopsy.
The global Melanoma Cancer Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Melanoma Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melanoma Cancer Diagnostics.
Report Scope
The Melanoma Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Melanoma Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Melanoma Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB Sciences
Incyte
Merck
Novartis
Pierre Fabre
Amgen
AstraZeneca
Bristol-Myers Squibb
Daiichi Sankyo
Segment by Type
Fluorescent In Situ Hybridization (FISH) Tests
Comparative Genomic Hybridization (CGH) Tests
Immunohistochemical (IHC) Tests
Segment by Application
Hospitals
Clinics
Cancer Research Centres
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Melanoma Cancer Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanoma Cancer Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fluorescent In Situ Hybridization (FISH) Tests
1.2.3 Comparative Genomic Hybridization (CGH) Tests
1.2.4 Immunohistochemical (IHC) Tests
1.3 Market by Application
1.3.1 Global Melanoma Cancer Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Melanoma Cancer Diagnostics Market Perspective (2019-2030)
2.2 Melanoma Cancer Diagnostics Growth Trends by Region
2.2.1 Global Melanoma Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Melanoma Cancer Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Melanoma Cancer Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Melanoma Cancer Diagnostics Market Dynamics
2.3.1 Melanoma Cancer Diagnostics Industry Trends
2.3.2 Melanoma Cancer Diagnostics Market Drivers
2.3.3 Melanoma Cancer Diagnostics Market Challenges
2.3.4 Melanoma Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Melanoma Cancer Diagnostics Players by Revenue
3.1.1 Global Top Melanoma Cancer Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Melanoma Cancer Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Melanoma Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Melanoma Cancer Diagnostics Revenue
3.4 Global Melanoma Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Melanoma Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanoma Cancer Diagnostics Revenue in 2023
3.5 Melanoma Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Melanoma Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Melanoma Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Melanoma Cancer Diagnostics Breakdown Data by Type
4.1 Global Melanoma Cancer Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Melanoma Cancer Diagnostics Forecasted Market Size by Type (2025-2030)
5 Melanoma Cancer Diagnostics Breakdown Data by Application
5.1 Global Melanoma Cancer Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Melanoma Cancer Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Melanoma Cancer Diagnostics Market Size (2019-2030)
6.2 North America Melanoma Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Melanoma Cancer Diagnostics Market Size by Country (2019-2024)
6.4 North America Melanoma Cancer Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Melanoma Cancer Diagnostics Market Size (2019-2030)
7.2 Europe Melanoma Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Melanoma Cancer Diagnostics Market Size by Country (2019-2024)
7.4 Europe Melanoma Cancer Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Melanoma Cancer Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Melanoma Cancer Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Melanoma Cancer Diagnostics Market Size (2019-2030)
9.2 Latin America Melanoma Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Melanoma Cancer Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Melanoma Cancer Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Melanoma Cancer Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Melanoma Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AB Sciences
11.1.1 AB Sciences Company Detail
11.1.2 AB Sciences Business Overview
11.1.3 AB Sciences Melanoma Cancer Diagnostics Introduction
11.1.4 AB Sciences Revenue in Melanoma Cancer Diagnostics Business (2019-2024)
11.1.5 AB Sciences Recent Development
11.2 Incyte
11.2.1 Incyte Company Detail
11.2.2 Incyte Business Overview
11.2.3 Incyte Melanoma Cancer Diagnostics Introduction
11.2.4 Incyte Revenue in Melanoma Cancer Diagnostics Business (2019-2024)
11.2.5 Incyte Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Melanoma Cancer Diagnostics Introduction
11.3.4 Merck Revenue in Melanoma Cancer Diagnostics Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Melanoma Cancer Diagnostics Introduction
11.4.4 Novartis Revenue in Melanoma Cancer Diagnostics Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Pierre Fabre
11.5.1 Pierre Fabre Company Detail
11.5.2 Pierre Fabre Business Overview
11.5.3 Pierre Fabre Melanoma Cancer Diagnostics Introduction
11.5.4 Pierre Fabre Revenue in Melanoma Cancer Diagnostics Business (2019-2024)
11.5.5 Pierre Fabre Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Melanoma Cancer Diagnostics Introduction
11.6.4 Amgen Revenue in Melanoma Cancer Diagnostics Business (2019-2024)
11.6.5 Amgen Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Melanoma Cancer Diagnostics Introduction
11.7.4 AstraZeneca Revenue in Melanoma Cancer Diagnostics Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Detail
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Melanoma Cancer Diagnostics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Melanoma Cancer Diagnostics Business (2019-2024)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Detail
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Melanoma Cancer Diagnostics Introduction
11.9.4 Daiichi Sankyo Revenue in Melanoma Cancer Diagnostics Business (2019-2024)
11.9.5 Daiichi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Melanoma Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Fluorescent In Situ Hybridization (FISH) Tests
Table 3. Key Players of Comparative Genomic Hybridization (CGH) Tests
Table 4. Key Players of Immunohistochemical (IHC) Tests
Table 5. Global Melanoma Cancer Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Melanoma Cancer Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Melanoma Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Melanoma Cancer Diagnostics Market Share by Region (2019-2024)
Table 9. Global Melanoma Cancer Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Melanoma Cancer Diagnostics Market Share by Region (2025-2030)
Table 11. Melanoma Cancer Diagnostics Market Trends
Table 12. Melanoma Cancer Diagnostics Market Drivers
Table 13. Melanoma Cancer Diagnostics Market Challenges
Table 14. Melanoma Cancer Diagnostics Market Restraints
Table 15. Global Melanoma Cancer Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Melanoma Cancer Diagnostics Market Share by Players (2019-2024)
Table 17. Global Top Melanoma Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Cancer Diagnostics as of 2023)
Table 18. Ranking of Global Top Melanoma Cancer Diagnostics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Melanoma Cancer Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Melanoma Cancer Diagnostics Product Solution and Service
Table 22. Date of Enter into Melanoma Cancer Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Melanoma Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Melanoma Cancer Diagnostics Revenue Market Share by Type (2019-2024)
Table 26. Global Melanoma Cancer Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Melanoma Cancer Diagnostics Revenue Market Share by Type (2025-2030)
Table 28. Global Melanoma Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Melanoma Cancer Diagnostics Revenue Market Share by Application (2019-2024)
Table 30. Global Melanoma Cancer Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Melanoma Cancer Diagnostics Revenue Market Share by Application (2025-2030)
Table 32. North America Melanoma Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Melanoma Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Melanoma Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Melanoma Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Melanoma Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Melanoma Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Melanoma Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Melanoma Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Melanoma Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Melanoma Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Melanoma Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Melanoma Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Melanoma Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Melanoma Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Melanoma Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 47. AB Sciences Company Detail
Table 48. AB Sciences Business Overview
Table 49. AB Sciences Melanoma Cancer Diagnostics Product
Table 50. AB Sciences Revenue in Melanoma Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 51. AB Sciences Recent Development
Table 52. Incyte Company Detail
Table 53. Incyte Business Overview
Table 54. Incyte Melanoma Cancer Diagnostics Product
Table 55. Incyte Revenue in Melanoma Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 56. Incyte Recent Development
Table 57. Merck Company Detail
Table 58. Merck Business Overview
Table 59. Merck Melanoma Cancer Diagnostics Product
Table 60. Merck Revenue in Melanoma Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 61. Merck Recent Development
Table 62. Novartis Company Detail
Table 63. Novartis Business Overview
Table 64. Novartis Melanoma Cancer Diagnostics Product
Table 65. Novartis Revenue in Melanoma Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Pierre Fabre Company Detail
Table 68. Pierre Fabre Business Overview
Table 69. Pierre Fabre Melanoma Cancer Diagnostics Product
Table 70. Pierre Fabre Revenue in Melanoma Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 71. Pierre Fabre Recent Development
Table 72. Amgen Company Detail
Table 73. Amgen Business Overview
Table 74. Amgen Melanoma Cancer Diagnostics Product
Table 75. Amgen Revenue in Melanoma Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 76. Amgen Recent Development
Table 77. AstraZeneca Company Detail
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Melanoma Cancer Diagnostics Product
Table 80. AstraZeneca Revenue in Melanoma Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Bristol-Myers Squibb Company Detail
Table 83. Bristol-Myers Squibb Business Overview
Table 84. Bristol-Myers Squibb Melanoma Cancer Diagnostics Product
Table 85. Bristol-Myers Squibb Revenue in Melanoma Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 86. Bristol-Myers Squibb Recent Development
Table 87. Daiichi Sankyo Company Detail
Table 88. Daiichi Sankyo Business Overview
Table 89. Daiichi Sankyo Melanoma Cancer Diagnostics Product
Table 90. Daiichi Sankyo Revenue in Melanoma Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 91. Daiichi Sankyo Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Melanoma Cancer Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Melanoma Cancer Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Fluorescent In Situ Hybridization (FISH) Tests Features
Figure 4. Comparative Genomic Hybridization (CGH) Tests Features
Figure 5. Immunohistochemical (IHC) Tests Features
Figure 6. Global Melanoma Cancer Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Melanoma Cancer Diagnostics Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Cancer Research Centres Case Studies
Figure 11. Others Case Studies
Figure 12. Melanoma Cancer Diagnostics Report Years Considered
Figure 13. Global Melanoma Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Melanoma Cancer Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Melanoma Cancer Diagnostics Market Share by Region: 2023 VS 2030
Figure 16. Global Melanoma Cancer Diagnostics Market Share by Players in 2023
Figure 17. Global Top Melanoma Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Cancer Diagnostics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Melanoma Cancer Diagnostics Revenue in 2023
Figure 19. North America Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Melanoma Cancer Diagnostics Market Share by Country (2019-2030)
Figure 21. United States Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Melanoma Cancer Diagnostics Market Share by Country (2019-2030)
Figure 25. Germany Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Melanoma Cancer Diagnostics Market Share by Region (2019-2030)
Figure 33. China Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Melanoma Cancer Diagnostics Market Share by Country (2019-2030)
Figure 41. Mexico Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Melanoma Cancer Diagnostics Market Share by Country (2019-2030)
Figure 45. Turkey Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Melanoma Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. AB Sciences Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2019-2024)
Figure 48. Incyte Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2019-2024)
Figure 49. Merck Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2019-2024)
Figure 51. Pierre Fabre Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2019-2024)
Figure 52. Amgen Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2019-2024)
Figure 53. AstraZeneca Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2019-2024)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2019-2024)
Figure 55. Daiichi Sankyo Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
